Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Doran International is a private French medical device company focused on intravenous infusion and perfusion systems used in healthcare settings. The company develops and manufactures products designed to protect drug integrity and improve safety during administration, with applications spanning infusion therapy, critical care, and oncology. Its marketed product families include Edelvaiss, a range of infusion circuit devices, and Kemoline, a line designed for chemotherapy drug administration. Doran International appears to operate as a commercial-stage medtech manufacturer rather than a therapeutics developer, with business activity centered on device development, production, and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Doran International.